(2S,4R)-5-(5′-chloro-2′-fluorobiphenyl-4-yl)-4-(ethoxyoxalylamino)-2-hydroxymethyl-2-methylpentanoic acid

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9868698
SERIAL NO

15581347

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

In one aspect, the invention relates to a compound of the structure:

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
THERAVANCE BIOPHARMA R&D IP LLCSOUTH SAN FRANCISCO CA 94080

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Beausoleil, Anne-Marie Redwood City, US 41 149
Fenster, Erik San Bruno, US 31 144
Fleury, Melissa Brisbane, US 110 1148
Hughes, Adam D Half Moon Bay, US 109 1192
Nzerem, Jerry South San Francisco, US 16 94
Rapta, Miroslav San Carlos, US 67 451
Thalladi, Venkat R Foster City, US 52 202

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Jul 16, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jul 16, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00